4 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
December 31, 2023 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
Level 1: Money market funds | $ | 15,635 | $ | — | $ | — | $ | 15,635 | ||||||||
Restricted cash | 116 | — | — | 116 | ||||||||||||
U.S. government securities | 76,875 | 104 | — | 76,979 | ||||||||||||
Total financial assets | $ | 92,626 | $ | 104 | $ | — | $ | 92,730 | ||||||||
Classified as: | ||||||||||||||||
Cash and cash equivalents | $ | 15,635 | ||||||||||||||
Restricted cash | 116 | |||||||||||||||
Short-term investments | 76,979 | |||||||||||||||
$ | 92,730 |
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
December 31, 2022 | ||||||||||||||||
Amortized Cost | Gross Unrealized Gains | Gross Unrealized Losses | Estimated Fair Value | |||||||||||||
Level 1: Money market funds | $ | 9,238 | $ | — | $ | — | $ | 9,238 | ||||||||
Restricted cash | 382 | — | — | 382 | ||||||||||||
U.S. government securities | 30,761 | — | (112) | 30,649 | ||||||||||||
Level 2: U.S. agency securities | 16,759 | — | (78) | 16,681 | ||||||||||||
Total financial assets | $ | 57,140 | $ | — | $ | (190) | $ | 56,950 | ||||||||
Classified as: | ||||||||||||||||
Cash and cash equivalents | $ | 9,238 | ||||||||||||||
Restricted cash | 382 | |||||||||||||||
Short-term investments | 47,330 | |||||||||||||||
$ | 56,950 |
- Prev
- 1
- Next